XLO
Xilio Therapeutics, Inc. - Common Stock (XLO)
$25
About Xilio Therapeutics, Inc. - Common Stock (XLO)
Xilio Therapeutics, Inc. operates as a biotechnology company. It focuses on the discovery and development of tumor-activated immuno-oncology therapies for the treatment of cancer. The firm uses its Geographically Precise Solutions (GPS) platform to develop tumor-activated molecules, including cytokines, antibodies and other biologics. The company was founded by John C. Williams and Ulrich Rodeck in June 2015 and is headquartered in Waltham, MA.
Details
Daily high
$8.65
Daily low
$7.78
Price at open
$8.45
52 Week High
$11.90
52 Week Low
$6.47
Market cap
57.3M
Dividend yield
-
Volume
27,227
Avg. volume
16,497
P/E ratio
-5.17
Xilio Therapeutics, Inc. - Common Stock News
Details
Daily high
$8.65
Daily low
$7.78
Price at open
$8.45
52 Week High
$11.90
52 Week Low
$6.47
Market cap
57.3M
Dividend yield
-
Volume
27,227
Avg. volume
16,497
P/E ratio
-5.17